2015
DOI: 10.1007/s00439-015-1561-6
|View full text |Cite
|
Sign up to set email alerts
|

ARL6IP6, a susceptibility locus for ischemic stroke, is mutated in a patient with syndromic Cutis Marmorata Telangiectatica Congenita

Abstract: Cutis Marmorata Telangiectatica Congenita (CMTC) is a congenital localized or generalized vascular anomaly, usually sporadic in occurrence. It can be associated with other cutaneous or systemic manifestations. About 300 cases have been reported. The molecular etiology remains largely unknown. The main purpose of this study is to delineate the molecular basis for a syndromic CMTC phenotype in a consanguineous Saudi family. Clinical phenotyping including detailed neurological imaging, followed by autozygosity ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 15 publications
0
13
0
Order By: Relevance
“…Arl6ip6 is a susceptibility locus for ischemic stroke [53]. It lacks enzyme-related domains, but does show physical interactions in proteome-wide pull-down screens with a number of proteins involved in membrane vesicle formation/targeting [33,54], a process that is involved in NE resealing and repair.…”
Section: Discussionmentioning
confidence: 99%
“…Arl6ip6 is a susceptibility locus for ischemic stroke [53]. It lacks enzyme-related domains, but does show physical interactions in proteome-wide pull-down screens with a number of proteins involved in membrane vesicle formation/targeting [33,54], a process that is involved in NE resealing and repair.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests a potential role in regulating the luminal aspects of NE specific structures, such as the LINC complex and associated torsinA, both of which may be regulated by disulfide oxidation/reduction [52,53]. Arl6ip6 is a susceptibility locus for ischemic stroke [54]. It lacks enzymerelated domains, but does show physical interactions in proteome-wide pull-down screens with a number of proteins involved in membrane vesicle formation/targeting [33,55], a process that is involved in NE resealing and repair.…”
Section: V5-arl6ip6mentioning
confidence: 99%
“…The pathogenesis of CMTC remains multifactorial. Homozygous truncating mutation in ARL6IP6 with syndromic form has been reported as a possible genetic cause for CMTC 2. However, there is no family history of vascular anomalies in the family of the reported case.…”
Section: Descriptionmentioning
confidence: 84%